Palbociclib in Combination With Fulvestrant Versus Fulvestrant in Advanced Breast Cancer: A Real-world Study in China
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: Breast Cancer|Fulvestrant|Palbociclib
Interventions: DRUG: Fulvestrant Injectable Product|DRUG: Palbociclib
Sponsor: Tianjin Medical University Cancer Institute and Hospital